HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Astroblastoma — Clinical Guidelines

Overview

Astroblastoma is a rare neuroepithelial tumor predominantly affecting children and young adults, characterized by perivascular pseudorosettes on histopathology 1 2 3 4. Its classification and therapeutic management remain subjects of ongoing discussion due to its rarity and ambiguous histogenesis 1.

Diagnosis

Clinical Presentation: Nonspecific symptoms including headaches, vomiting, decreased visual acuity, and loss of consciousness 1.

Imaging: CT and MRI often reveal solid-cystic masses with heterogeneous enhancement and perilesional edema 1.

Histopathology: Key diagnostic feature is the presence of perivascular pseudorosettes; immunohistochemical markers include GFAP, EMA, vimentin, and S100 positivity 1 2 4.

Differentiation: Distinguishes from other glial tumors by its distinct pattern and typically longer clinical course 2.

Management

Surgical Resection: Primary treatment involves complete tumor resection when feasible 1 2 3.

Recurrence Management: Repeat resections may be necessary in cases of recurrence, as seen in pediatric cases 2.

Adjuvant Therapy: No specific adjuvant therapies are widely recommended based on the provided abstracts; management often relies on surgical outcomes 1 2 3 4.

Special Populations

Pediatrics: Astroblastoma can occur in children with prolonged clinical courses and multiple resections possible 2.

Elderly: Limited data; primarily described in younger populations 1 2 3 4.

Comorbidities: No specific guidance provided in the abstracts regarding comorbidities 1 2 3 4.

Key Recommendations

Surgical resection should be considered the primary treatment approach for astroblastoma to achieve complete removal when possible (Evidence: Moderate 1 2 3).

Histopathological examination with immunohistochemical staining is essential for confirming the diagnosis, focusing on perivascular pseudorosettes and GFAP positivity (Evidence: Moderate 1 2 4).

Close monitoring and potential repeat resections may be necessary in pediatric cases due to the tumor's tendency for recurrence (Evidence: Weak 2).

References

1 Regragui M, Karkouri M, Ibahioin K, El Azhari A. [Astroblastoma: A rare glial tumor]. Annales de pathologie 2018. link 2 Husain AN, Leestma JE. Cerebral astroblastoma: immunohistochemical and ultrastructural features. Case report. Journal of neurosurgery 1986. link 3 Hoag G, Sima AA, Rozdilsky B. Astroblastoma revisited: a report of three cases. Acta neuropathologica 1986. link 4 Yamashita J, Handa H, Yamagami T, Haebara H. Astroblastoma of pure type. Surgical neurology 1985. link90188-0)

Astroblastoma